White, MB, CHB, DSc, served as Guest Editor for this paper. (2) now showed that even among people at risk for HFpEF, an increased E/e 0 identified patients with limited exercise capacity.
CLINICAL IMPLICATIONS
More than one-half of people with HF have preserved EF and, in SBHF, the data from Kosmala et al. (6, 7, 11, 12) . Intriguingly, in the asymptomatic patients with SBHF studied, there was also more severe chronotropic incompetence as more abnormalities in LV strain, LVH, and E/e 0 were observed (2) . Indeed, evidence of progressively lower peak VO 2 with increasing numbers of abnormalities is strikingly similar to previous data from our group comparing older-aged healthy volunteers to asymptomatic hypertensives (with SBHF)
with patients with HFpEF, who have progressively more cardiovascular limitations and worse exercise capacity (13) . In light of prior research, the findings from the current study strongly support the researchers' conclusion that abnormal strain and E/e 0 should be added to the current scheme by which we define SBHF (2).
What might be the implications if this new definition of SBHF is accepted? First, the pool of patients with SBHF will grow substantially-indeed, it doubled in the current study beyond use of LVH alone. This creates a larger cohort of patients in whom strategies can be tested to prevent HF. It is notable that Kosmala et al. observed that strain, E/e 0 , and LVH were each individually more predictive of exercise capacity than BNP, suggesting that these novel echocardiography parameters could be used as entry criteria for future trials.
Finally, the current data questioned whether these patients are truly "asymptomatic." When caregivers ask about dyspnea, patients consider it in light of their daily routine, which may be limited if they are sedentary. The fact that striking reductions in peak VO 2 were observed in patients with abnormal strain and E/e 0 suggests that these patients may not be as asymptomatic as they (or we) think they are.
Appropriate use of strain and E/e 0 in clinical practice requires standardization of echocardiography instruments and techniques. Confirmatory data from larger trials employing strain and diastolic function parameters will be important moving forward. Maybe the time has come to routinely apply these sensitive systolic and diastolic echocardiography parameters in our approach to patients with and at risk for HF.
Kosmala et al.'s investigation urges us to do so sooner rather than later.
